Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · CMS publication 2026-06-30 View official record

Covered recipient · General Payments record

JOE JOHN STEPHENSON

Allopathic & Osteopathic Physicians Internal Medicine Hematology & Oncology

NPI
1346245552
CMS profile
242896
Location
GREENVILLE, SC

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

Saved items

Saved only in this browser. No account or alerts.

Filter and download payment records

General Payments · PY2023 · Entire year

$1,014.59

42 records · 0 disputed

Summary and payment records

  • CMS publication 2026-06-30
Read the payment records

“Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.”

— Centers for Medicare & Medicaid Services, Open Payments

A reported payment reflects a financial relationship a company disclosed. It does not indicate wrongdoing or a conflict of interest, and it says nothing about the quality of a provider's care.

These records are submitted to CMS and attested to by the reporting companies. CMS publishes them as reported; this site mirrors them without independent verification.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

How these totals are calculated
  • This total is the sum of the individual General Payments record amounts CMS published for the labeled program year(s); each record amount is used unmodified. The total itself is computed by this site. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Methodology & Data — sourcing, labeling, and limitations.

Provider summaries generated . CMS updates this data on an annual cycle, and corrections or successful disputes made at CMS may not yet appear here. The official CMS record is authoritative for the current state. View the official CMS record ↗

By nature of payment

PY2023 · entire year · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $847.93 40
Long term medical supply or device loan $166.66 2

By paying entity

PY2023 · entire year · sorted by reported total

Page 1 of 1; records 1–42 of 42 matching records. This page contains 42 records (maximum 50), not the full filtered export. Use the CSV download for all matching records.

IndustryPayments · General Payments

JOE JOHN STEPHENSON

NPI 1346245552 · CMS profile ID 242896

Allopathic & Osteopathic Physicians / Internal Medicine / Hematology & Oncology

GREENVILLE, SC

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

General Payments, PY2023; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types

Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00

Page 1 of 1; records 1–42 of 42 matching records. This page contains 42 records (maximum 50), not the full filtered export.

Filtered page: https://industrypayments.org/provider/npi-1346245552?year=2023&recipient=provider#records-h

CMS source: https://openpaymentsdata.cms.gov/dataset/fb3a65aa-c901-4a38-a813-b04b00dfa2a9

Cite these filtered records

The citation includes this program year, filters, data edition, and page of results.

Plain
JOE JOHN STEPHENSON, NPI 1346245552, CMS profile ID 242896. General Payments, PY2023; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 1 of 1; records 1–42 of 42 matching records. This page contains 42 records (maximum 50), not the full filtered export. IndustryPayments. https://industrypayments.org/provider/npi-1346245552?year=2023&recipient=provider#records-h. Source: https://openpaymentsdata.cms.gov/dataset/fb3a65aa-c901-4a38-a813-b04b00dfa2a9.
APA 7
IndustryPayments. (2026). JOE JOHN STEPHENSON, NPI 1346245552, CMS profile ID 242896. General Payments, PY2023; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 1 of 1; records 1–42 of 42 matching records. This page contains 42 records (maximum 50), not the full filtered export. [Filtered data set page]. https://industrypayments.org/provider/npi-1346245552?year=2023&recipient=provider#records-h. Source: https://openpaymentsdata.cms.gov/dataset/fb3a65aa-c901-4a38-a813-b04b00dfa2a9.
Bluebook
JOE JOHN STEPHENSON, NPI 1346245552, CMS profile ID 242896, IndustryPayments, General Payments, PY2023; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types (Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00). Page 1 of 1; records 1–42 of 42 matching records. This page contains 42 records (maximum 50), not the full filtered export. Source: https://openpaymentsdata.cms.gov/dataset/fb3a65aa-c901-4a38-a813-b04b00dfa2a9. https://industrypayments.org/provider/npi-1346245552?year=2023&recipient=provider#records-h.

Centers for Medicare & Medicaid Services, Open Payments

Citation formats are provided for reference; check the requirements of your publication.

Payment records · PY2023

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

General Payments · PY2023 · Physicians and non-physician practitioners · CMS publication 2026-06-30

42 matching records · $1,014.59 reported total · 0 disputed

Nature of payment: All payment types

Records imported here (UTC).

Link to these filtered records · CMS source dataset ↗

Download all 42 matching records (CSV)

CSV includes CMS record IDs, source and publication dates, the data edition, and a link to these filters. Formula-like text cells are prefixed with an apostrophe for spreadsheet safety.

Showing records 1–42 of 42.

Paying entityAmountDate Nature of paymentDispute statusPublication flagsPublished Record IDSource
Alnylam Pharmaceuticals Inc. $21.7112/14/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1006148185 CMS
Novartis Pharmaceuticals Corporation $23.2712/05/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 993356669 CMS
Merck Sharp & Dohme LLC $16.9711/29/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1048394591 CMS
BeiGene USA, Inc. $18.7311/15/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1051197297 CMS
Seagen Inc. $17.1210/31/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 995671123 CMS
Takeda Pharmaceuticals U.S.A., Inc. $18.3410/25/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1055622369 CMS
Gilead Sciences, Inc. $25.5910/20/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1025617265 CMS
Celgene Corporation $18.4510/05/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1015497897 CMS
Genmab U.S., Inc. $26.0509/27/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1051345351 CMS
Daiichi Sankyo Inc. $24.8209/14/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1006497707 CMS
Gilead Sciences, Inc. $27.9309/08/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1025582305 CMS
Merck Sharp & Dohme LLC $30.0809/06/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1048389699 CMS
PFIZER INC. $16.0708/30/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1050508779 CMS
PFIZER INC. $15.8408/29/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1050506269 CMS
Seagen Inc. $18.7408/10/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 995670924 CMS
Daiichi Sankyo Inc. $22.0108/03/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1006471021 CMS
Seagen Inc. $22.9108/02/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 995670909 CMS
BeiGene USA, Inc. $16.0608/01/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1051197299 CMS
Seagen Inc. $22.7707/26/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 995670889 CMS
Novartis Pharmaceuticals Corporation $24.4607/25/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 993356663 CMS
Foundation Medicine, Inc. $14.4207/20/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1058787715 CMS
Agios Pharmaceuticals, Inc. $14.5907/18/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1056211617 CMS
Eisai Inc. $18.3107/13/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1023315163 CMS
Bayer Healthcare Pharmaceuticals Inc. $28.7806/30/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1000526237 CMS
Exelixis Inc. $15.4106/29/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1044575593 CMS
Novo Nordisk Inc $17.3406/20/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1003060641 CMS
Kite Pharma, Inc. $27.2506/16/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1025274019 CMS
AstraZeneca Pharmaceuticals LP $20.0406/08/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1014177041 CMS
Bayer Healthcare Pharmaceuticals Inc. $20.4106/06/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1000512709 CMS
Medtronic, Inc. $30.7805/31/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1019544379 CMS
Eisai Inc. $21.1805/12/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1023315161 CMS
Amgen Inc. $15.1105/09/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1020602107 CMS
Astellas Pharma US Inc $28.8305/03/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1034090339 CMS
AstraZeneca Pharmaceuticals LP $17.8104/27/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1015747441 CMS
Astellas Pharma US Inc $16.3004/26/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1034079185 CMS
Bayer Healthcare Pharmaceuticals Inc. $23.6004/20/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1000518947 CMS
Celgene Corporation $18.7803/28/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1015497729 CMS
Merck Sharp & Dohme LLC $20.9103/15/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1048394587 CMS
Regeneron Healthcare Solutions, Inc. $25.9202/22/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 999467505 CMS
NOVARTIS PHARMACEUTICALS CORPORATION $83.3302/15/2023 Long term medical supply or device loan No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 993433449 CMS
Bayer Healthcare Pharmaceuticals Inc. $24.2402/06/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1000519933 CMS
NOVARTIS PHARMACEUTICALS CORPORATION $83.3301/14/2023 Long term medical supply or device loan No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 993433447 CMS

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2019 $21,556.24 31
PY2020 $17,473.50 17
PY2021 $13,987.22 27
PY2022 $1,610.37 17
PY2023 $1,014.59 42
PY2024 $1,085.87 38
PY2025 $298.58 14

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-06-30
Program years on this page
2019, 2020, 2021, 2022, 2023, 2024, 2025
Source files and profile matching
Generated from
OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.

Research Payments

One row per program year and role, newest year first · amounts for the two roles are never added together

Program yearRoleAmountRecords
PY2021 Recipient $38.20 1
PY2021 Principal investigator $90.00 1
PY2020 Principal investigator $800.00 5
PY2019 Principal investigator $541.50 2

Research Payments are a separate CMS dataset, shown here separately and never added to General Payments. A research payment is often made to an institution, with this provider named as a principal investigator; each record states which role applies.

“If you are a physician who served as a principal investigator on a research study, you may see the payments associated with that research study listed under your name. This does not necessarily mean the payments are attributed to you. The dollar amount of the record corresponds to the total payment; the amounts are not attributed to each individual on the record.”

— Centers for Medicare & Medicaid Services, Open Payments Frequently Asked Questions, FAQ #12224

Research Payments records · PY2020

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

5 records in PY2020

Research Payments records (CSV)

RolePaying entityAmount DateRecipientStudy Dispute statusPublishedRecord ID
Principal investigator 1 Merck Sharp & Dohme Corporation $100.00 11/24/2020 Non-covered Recipient Entity
GREENVILLE NCORP
A Randomized, Phase III Trial to Evaluate the Efficacy and Safety of MK-3475 as Adjuvant Therapy for Triple Receptor-Negative Breast Cancer with 1 cm Residual Invasive Cancer or Positive Lymph Nodes pN1mic After Neoadjuvant Chemotherapy No dispute reported 06/30/2026 740830981
Principal investigator 1 Merck Sharp & Dohme Corporation $100.00 11/24/2020 Non-covered Recipient Entity
GREENVILLE NCORP
A Randomized, Phase III Trial to Evaluate the Efficacy and Safety of MK-3475 as Adjuvant Therapy for Triple Receptor-Negative Breast Cancer with 1 cm Residual Invasive Cancer or Positive Lymph Nodes pN1mic After Neoadjuvant Chemotherapy No dispute reported 06/30/2026 740830983
Principal investigator 1 Merck Sharp & Dohme Corporation $50.00 11/24/2020 Non-covered Recipient Entity
GREENVILLE NCORP
A Randomized, Phase III Trial to Evaluate the Efficacy and Safety of MK-3475 as Adjuvant Therapy for Triple Receptor-Negative Breast Cancer with 1 cm Residual Invasive Cancer or Positive Lymph Nodes pN1mic After Neoadjuvant Chemotherapy No dispute reported 06/30/2026 740830991
Principal investigator 1 Merck Sharp & Dohme Corporation $50.00 11/24/2020 Non-covered Recipient Entity
GREENVILLE NCORP
A Randomized, Phase III Trial to Evaluate the Efficacy and Safety of MK-3475 as Adjuvant Therapy for Triple Receptor-Negative Breast Cancer with 1 cm Residual Invasive Cancer or Positive Lymph Nodes pN1mic After Neoadjuvant Chemotherapy No dispute reported 06/30/2026 740831161
Principal investigator 1 Merck Sharp & Dohme Corporation $500.00 10/06/2020 Non-covered Recipient Entity
BAPTIST MU NCORP
A Randomized, Phase III Trial to Evaluate the Efficacy and Safety of MK-3475 as Adjuvant Therapy for Triple Receptor-Negative Breast Cancer with 1 cm Residual Invasive Cancer or Positive Lymph Nodes pN1mic After Neoadjuvant Chemotherapy No dispute reported 06/30/2026 740831675